Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 290075011000036110 | mercaptamine (cysteamine) 150 mg capsule (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 290076011000036115 | mercaptamine (cysteamine) 150 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| mercaptamine (cysteamine) 150 mg capsule | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| mercaptamine (cysteamine) 150 mg capsule | Is a | mercaptamine (cysteamine) | true | Inferred relationship | Some | ||
| mercaptamine (cysteamine) 150 mg capsule | has intended active ingredient | mercaptamine (cysteamine) | true | Inferred relationship | Some | 340033290 | |
| mercaptamine (cysteamine) 150 mg capsule | has Australian BoSS | mercaptamine (cysteamine) | true | Inferred relationship | Some | 340033290 | |
| mercaptamine (cysteamine) 150 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| mercaptamine (cysteamine) 150 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 340033291 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cystagon 150 mg capsule | Is a | True | mercaptamine (cysteamine) 150 mg capsule | Inferred relationship | Some | |
| mercaptamine (cysteamine) 150 mg capsule, 500 | has MPUU | True | mercaptamine (cysteamine) 150 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR